Retirees stuck in the middle of debate over drug-price reform By: MarketWatch June 08, 2021 at 16:34 PM EDT How a popular prescription-affordability fix could backfire on both taxpayers and patients. Read More >> Related Stocks: Biogen Idec Bristol-Myers Squibb Pfizer